...
search icon
gh-img

Guardant Health Inc Share Price

GH
NSQ
$105.03
-$0.31
(-0.29%)
1D
Industry: Health Care Providers & Services Sector: Health Care

Guardant Health Inc Analyst Forecast

Guardant Health Inc Share Price Chart

Guardant Health Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.68B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.18M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.65
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$34.88 L
$120.74 H
$105.03

About Guardant Health Inc, Common Stock

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California. more

Industry: Health Care Providers & ServicesSector: Health Care

Guardant Health Inc Stock Returns

Time FrameGHSectorS&P500
1-Week Return-7.09%1.44%0.64%
1-Month Return-2.36%-0.67%-0.17%
3-Month Return7.26%6.14%1.88%
6-Month Return91.66%19.98%9.19%
1-Year Return136.55%6.85%14.76%
3-Year Return275.24%17.99%70.19%
5-Year Return-35.17%34.54%77.96%
10-Year Return226.18%142.13%275.69%

Guardant Health Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue286.73M373.65M449.54M563.95M739.02M[{"date":"2020-12-31","value":38.8,"profit":true},{"date":"2021-12-31","value":50.56,"profit":true},{"date":"2022-12-31","value":60.83,"profit":true},{"date":"2023-12-31","value":76.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue92.53M122.91M156.32M227.05M289.80M[{"date":"2020-12-31","value":31.93,"profit":true},{"date":"2021-12-31","value":42.41,"profit":true},{"date":"2022-12-31","value":53.94,"profit":true},{"date":"2023-12-31","value":78.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit194.19M250.74M293.21M336.90M449.22M[{"date":"2020-12-31","value":43.23,"profit":true},{"date":"2021-12-31","value":55.82,"profit":true},{"date":"2022-12-31","value":65.27,"profit":true},{"date":"2023-12-31","value":75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin67.73%67.11%65.23%59.74%60.79%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.08,"profit":true},{"date":"2022-12-31","value":96.31,"profit":true},{"date":"2023-12-31","value":88.2,"profit":true},{"date":"2024-12-31","value":89.75,"profit":true}]
Operating Expenses449.14M661.74M837.59M901.62M892.81M[{"date":"2020-12-31","value":49.82,"profit":true},{"date":"2021-12-31","value":73.39,"profit":true},{"date":"2022-12-31","value":92.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.02,"profit":true}]
Operating Income(254.95M)(411.00M)(544.38M)(564.73M)(443.59M)[{"date":"2020-12-31","value":-25495000000,"profit":false},{"date":"2021-12-31","value":-41100100000,"profit":false},{"date":"2022-12-31","value":-54437800000,"profit":false},{"date":"2023-12-31","value":-56472500000,"profit":false},{"date":"2024-12-31","value":-44359400000,"profit":false}]
Total Non-Operating Income/Expense14.45M27.88M(105.58M)118.75M59.62M[{"date":"2020-12-31","value":12.17,"profit":true},{"date":"2021-12-31","value":23.48,"profit":true},{"date":"2022-12-31","value":-88.91,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":50.2,"profit":true}]
Pre-Tax Income(245.90M)(384.47M)(653.45M)(478.76M)(435.09M)[{"date":"2020-12-31","value":-24590400000,"profit":false},{"date":"2021-12-31","value":-38447000000,"profit":false},{"date":"2022-12-31","value":-65344900000,"profit":false},{"date":"2023-12-31","value":-47876400000,"profit":false},{"date":"2024-12-31","value":-43508900000,"profit":false}]
Income Taxes379.00K300.00K1.14M685.00K1.28M[{"date":"2020-12-31","value":29.52,"profit":true},{"date":"2021-12-31","value":23.36,"profit":true},{"date":"2022-12-31","value":88.71,"profit":true},{"date":"2023-12-31","value":53.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(246.28M)(384.77M)(654.59M)(479.45M)(436.37M)[{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false},{"date":"2024-12-31","value":-43637300000,"profit":false}]
Income From Continuous Operations(246.28M)(384.77M)(654.59M)(479.45M)(436.37M)[{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false},{"date":"2024-12-31","value":-43637300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(253.78M)(405.67M)(654.59M)(479.45M)(436.37M)[{"date":"2020-12-31","value":-25378300000,"profit":false},{"date":"2021-12-31","value":-40567000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false},{"date":"2024-12-31","value":-43637300000,"profit":false}]
EPS (Diluted)(2.58)(4.00)(5.25)(3.55)(3.28)[{"date":"2020-12-31","value":-258,"profit":false},{"date":"2021-12-31","value":-400,"profit":false},{"date":"2022-12-31","value":-525,"profit":false},{"date":"2023-12-31","value":-355,"profit":false},{"date":"2024-12-31","value":-328,"profit":false}]

Guardant Health Inc Ratios

Guardant Health Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GH
Cash Ratio 2.45
Current Ratio 3.50
Quick Ratio 3.12

Guardant Health Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GH
ROA (LTM) -19.64%
ROE (LTM) -4584.47%

Guardant Health Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GH
Debt Ratio Lower is generally better. Negative is bad. 1.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.28

Guardant Health Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GH
Trailing PE NM
Forward PE NM
P/S (TTM) 15.16
P/B 55.67
Price/FCF NM
EV/R 15.48
EV/Ebitda NM

FAQs

What is Guardant Health Inc share price today?

Guardant Health Inc (GH) share price today is $105.03

Can Indians buy Guardant Health Inc shares?

Yes, Indians can buy shares of Guardant Health Inc (GH) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Guardant Health Inc be purchased?

Yes, you can purchase fractional shares of Guardant Health Inc (GH) via the Vested app. You can start investing in Guardant Health Inc (GH) with a minimum investment of $1.

How to invest in Guardant Health Inc shares from India?

You can invest in shares of Guardant Health Inc (GH) via Vested in three simple steps:

  • Click on Sign Up or Invest in GH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Guardant Health Inc shares
What is Guardant Health Inc 52-week high and low stock price?

The 52-week high price of Guardant Health Inc (GH) is $120.74. The 52-week low price of Guardant Health Inc (GH) is $34.88.

What is Guardant Health Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Guardant Health Inc (GH) is

What is Guardant Health Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Guardant Health Inc (GH) is 55.67

What is Guardant Health Inc dividend yield?

The dividend yield of Guardant Health Inc (GH) is 0.00%

What is the Market Cap of Guardant Health Inc?

The market capitalization of Guardant Health Inc (GH) is $13.68B

What is Guardant Health Inc's stock symbol?

The stock symbol (or ticker) of Guardant Health Inc is GH

How Can Investors Use Guardant Health Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Guardant Health Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Guardant Health Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Guardant Health Inc shares for Indian investors?

When investing in Guardant Health Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Guardant Health Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Guardant Health Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Guardant Health Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Guardant Health Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top